Beijing Chunlizhengda Medical Instruments Co Ltd (688236) — Capital Reinvestment Ratio

Latest as of September 2025: 0.56x

Beijing Chunlizhengda Medical Instruments Co Ltd (688236) has a Capital Reinvestment Ratio of 0.56x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥33.08 Million) in capital expenditures (CN¥18.38 Million). See 688236 equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.56x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥33.08 Million
CNY

Capital Expenditures

CN¥18.38 Million
CNY

Data as of

Sep 2025
Most recent filing

Beijing Chunlizhengda Medical Instruments Co Ltd Capital Reinvestment Ratio (2012–2023)

This chart tracks Beijing Chunlizhengda Medical Instruments Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check cash flow reinvestment rate of Beijing Chunlizhengda Medical Instrument to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd (2012–2023)

Year-by-year Capital Reinvestment Ratio for Beijing Chunlizhengda Medical Instruments Co Ltd from 2012 to 2023. For live market cap and broader valuation context, see Beijing Chunlizhengda Medical Instrument market capitalisation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 0.06x CN¥511.71 Million CN¥33.24 Million ▼ -89.3%
2022 0.61x CN¥41.01 Million CN¥24.90 Million ▼ -49.8%
2021 1.21x CN¥164.79 Million CN¥199.41 Million ▲ +1214.1%
2020 0.09x CN¥260.68 Million CN¥24.00 Million ▼ -83.9%
2019 0.57x CN¥231.54 Million CN¥132.41 Million ▲ +19.1%
2018 0.48x CN¥108.51 Million CN¥52.12 Million ▲ +380.4%
2017 0.10x CN¥89.83 Million CN¥8.98 Million ▼ -22.3%
2016 0.13x CN¥64.95 Million CN¥8.36 Million ▼ -73.5%
2014 0.48x CN¥24.27 Million CN¥11.77 Million ▲ +104.0%
2013 0.24x CN¥28.20 Million CN¥6.70 Million ▲ +6.9%
2012 0.22x CN¥28.83 Million CN¥6.41 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow